Top Medical Searches

Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX Multi-Cord Study

Safety Profile Consistent with Clinical Trials MALVERN, Pa., Sept. 7, 2011 /PRNewswire/ — AuxiliumPharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceuticalcompany, today announced positive top-line results from a pilotclinical…


 Read more…

Be Sociable, Share!
September 7th, 2011 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us